Soleno Therapeutics, Inc.SLNONASDAQ

Revenue (LTM)

$190M

Net Income (LTM)

$21M

+111.9% YoY

Free Cash Flow

$47M

Revenue CAGR (5Y)

—

—Marginsstable

FCFTurned positive

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	190
Gross Profit	0	0	0	0	188
Operating Income	-32	-24↑22.6%	-41↓69.6%	-188↓353.5%	15↑108.0%
Net Income	-31	-24↑22.1%	-39↓62.0%	-176↓351.0%	21↑111.9%
EBITDA	-30	-22↑27.0%	-37↓67.5%	-174↓368.9%	28↑116.3%
EPS Diluted	-5.81	-2.87↑50.6%	-2.36↑17.8%	-4.38↓85.6%	0.39↑108.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	21	15↓31.5%	170↑1062.0%	88↓48.2%	70↓20.3%
Total Current Assets	22	16↓30.2%	171↑995.1%	294↑71.5%	356↑21.1%
Total Assets	36	26↓25.5%	181↑581.9%	331↑83.2%	564↑70.4%
Total Current Liabilities	8	7↓8.7%	12↑57.3%	19↑62.9%	61↑227.3%
Total Liabilities	18	16↓9.1%	23↑43.6%	86↑270.3%	114↑32.4%
Total Equity	18	10↓41.8%	158↑1422.1%	245↑55.6%	450↑83.6%
Total Debt	0	0↓66.1%	0↑160.0%	53↑13008.2%	3↓94.9%
Net Debt	-21	-14↑30.7%	-169↓1071.7%	-35↑79.3%	-67↓92.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-28	-21↑25.2%	-25↓20.0%	-69↓177.0%	47↑167.7%
Capital Expenditure	-0	-0↑40.9%	0	-0	-0↑66.5%
Free Cash Flow	-28	-21↑25.2%	-25↓19.9%	-69↓177.9%	47↑167.4%
Stock-Based Comp	3	3↓22.8%	6↑135.0%	100↑1581.4%	46↓54.1%
Net Change in Cash	-28	-7↑76.0%	155↑2413.9%	-82↓152.7%	-18↑78.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance